Jones_2016_Molecules_21_

Reference

Title : Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer's Disease - Jones_2016_Molecules_21_
Author(s) : Jones M , Wang J , Harmon S , Kling B , Heilmann J , Gilmer JF
Ref : Molecules , 21 : , 2016
Abstract :

Isosorbide-2-carbamates-5-aryl esters are highly potent and very selective butyrylcholinesterase inhibitors. The objective of the present work was to address the hypothesis that the isosorbide-aryl-5-ester group could be replaced with an antioxidant functionality while maintaining inhibitor effects and selectivity. We successfully incorporated ferulic acid or lipoic acid groups producing potent selective inhibitors of butyrylcholinesterase (BuChE). The hybrid compounds were non-toxic to the murine hippocampal cell line HT-22 and lipoate esters were neuroprotective at 10 and 25 microM when the cells were challenged with glutamate (5 mM) in a similar manner to the positive control quercetin. The benzyl carbamate 7a was a potent inhibitor of BuChE (IC50 150 nM) and it was effective in reducing glutamate toxicity to neuronal cells at >5 microM. Representative compounds exhibited an antioxidant effect in the oxygen radical absorbance capacity assay as the lipoate 7d was not active, whereas the ferulate 8a showed a weak, but significant, activity with 0.635 +/- 0.020 Trolox Equivalent.

PubMedSearch : Jones_2016_Molecules_21_
PubMedID: 27534722

Related information

Citations formats

Jones M, Wang J, Harmon S, Kling B, Heilmann J, Gilmer JF (2016)
Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer's Disease
Molecules 21 :

Jones M, Wang J, Harmon S, Kling B, Heilmann J, Gilmer JF (2016)
Molecules 21 :